Re: Q2 Results
|
1
|
Mannkind
|
Aug 10, 2013 08:01AM
|
A Good Drug That's Too Risky to Buy
|
|
Mannkind
|
Aug 11, 2013 04:11PM
|
Re: Frustrating game!
|
1
|
Mannkind
|
Aug 12, 2013 11:35AM
|
Re: trial results
|
|
Mannkind
|
Aug 12, 2013 09:18PM
|
Investors Purchase High Volume of MannKind Corp. Put Options (MNKD)
|
|
Mannkind
|
Aug 12, 2013 09:36PM
|
Re: trial results
|
3
|
Mannkind
|
Aug 13, 2013 09:38AM
|
Zacks
|
|
Mannkind
|
Aug 13, 2013 09:47AM
|
MannKind (MNKD) Affinity Trials Should be Low Risk, But Afrezza Approval Not Gua
|
1
|
Mannkind
|
Aug 13, 2013 10:29AM
|
Re: Renaissance Technologies
|
1
|
Mannkind
|
Aug 13, 2013 02:38PM
|
Re: Renaissance Technologies
|
|
Mannkind
|
Aug 13, 2013 06:15PM
|
Cramer
|
|
Mannkind
|
Aug 13, 2013 09:51PM
|
An All-In Bet on a Game-Changing Diabetes Treatment
|
1
|
Mannkind
|
Aug 13, 2013 09:54PM
|
Re: My Phase III Estimated Results Release Date
|
4
|
Mannkind
|
Aug 14, 2013 08:31AM
|
MannKind Rises After Inhaled Insulin Meets Goals in Study
|
|
Mannkind
|
Aug 14, 2013 10:10AM
|
MannKind Leaps Giant Hurdle With Afrezza Study
|
|
Mannkind
|
Aug 14, 2013 11:43AM
|
Re: Quick question
|
|
Mannkind
|
Aug 14, 2013 03:46PM
|
MannKind downgraded earlier to Market Perform from Outperform at JMP
|
1
|
Mannkind
|
Aug 14, 2013 06:05PM
|
Re: CC transcript
|
|
Mannkind
|
Aug 14, 2013 09:13PM
|
Trials Show MannKind’s Inhaled Insulin More Effective Than Injected, Oral Treatm
|
|
Mannkind
|
Aug 15, 2013 07:03AM
|
Joy for MannKind as inhaled insulin shines in PhIII
|
|
Mannkind
|
Aug 15, 2013 07:16AM
|